Access 2.8M+ Filings Sign Up Free
Transgene Logo

Transgene | TNG - Profile, Filings, Stock Info & Investor Relations Data

Transgene | TNG
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
France
Founded
1979
Transgene (TNG)

Company Profile

Website
Investor Relations

About Transgene

Transgene is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer.

A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer.

Our approach uses the mechanisms of the immune response to enable the patient’s body to fight against disease.

Employees

160

Market Presence

Worldwide

Headquarters

400 BOULEVARD GONTHIER D'ANDERNACH
67400, ILLKIRCH-GRAFFENSTADEN
France

Transgene (TNG)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Transgene (TNG)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

◆
N/A (Other)
Other EUR 32,999,999.57 EUR 1.07 30.07.24
↑
N/A (Other)
Buy EUR 0.00 EUR 0.00 26.05.23

Transgene (TNG)
Stock & Investor Information

ISINs

FR0005175080

LEI

969500PDJW8N0FSGGK69

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View Transgene on main exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology